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ABSTRACT
A NEUROPROTECTIVE ROLE FOR MIR-1017,A NON-CANONICAL MIRNA
by Matthew Anthony de Cruz
December 2017
miRNAs are post-transcriptional regulators of gene expression, with
numerous being involved in neurobiology. Within the human genome a quarter of
the identified miRNA loci derive from a class of miRNAs termed tailed mirtrons.
Despite the identification of this large population of miRNA, no functional studies
have been conducted to identify their role. In this study we examined the highly
expressed and deeply conserved Drosophila 3’ tail mirtron, miR-1017, as a
candidate to elucidate tailed mirtron functionality. We identified acetylcholine
receptor transcripts, D5 and D2, as bona fide targets for miR-1017.
Interestingly, D2 is also the host transcript for miR-1017. We utilized the
GAL4/UAS system, to observe the miR-1017 expression pattern; furthermore we
witnessed a disrupted feedback loop in the miR-1017 null background resulting in
higher D2 transcriptional activation. This could be phenocopied with the
acetylcholine receptor (AchR) activity antagonist, Donepezil, which likewise
resulted in higher GFP expression. Together this suggests that D2 transcription
is modulated by acetylcholine neurotransmission. Consistent with a role in
dampening AchR activity miR-1017 mutant flies exhibit a neurodegeneration due
to excitotoxicity. Ectopic expression of miR-1017 within an Alzhiemers disease fly
model dampened the pathologenesis and improved neurological function and
lifespan. Therefore revealing miR-1017, a 3’ tailed mirtron, as a significant
ii

neuroprotector within Drosophila. The coupled expression of D2 and miR-1017
works as a negative feedback loop that limits activity dependent transcription of
D2.
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CHAPTER I – INTRODUCTION
1.1 miRNAs as Gene Regulators
Over the last two decades miRNAs have widely become recognized as
common post-transcriptional regulators of gene expression1. miRNAs have been
identified in Plants, Animals and Viruses and have numerous roles including
physiological response and cell differentiation during development2,3.
Furthermore when miRNAs are dysregulated it can cause serious health
problems including cancer4,5. Animal miRNAs are 22 nucleotides (nt) in length
and only require 6-8 nt of complementarity to a target mRNA transcript6. The
seed region of the mature miRNA, nt 2-8, is responsible for complementation to
the mRNA7. Once bound to Argonaute (Ago) proteins and their target transcripts,
miRNAs perturb ribosomal translation and cause mRNA degradation 8.
In 1993 the first miRNA was identified and hypotheses ensued suggesting
that small RNA molecules could cause posttranscriptional gene silencing. The
seminal studies in C. elegans examined heterochronic genes in larval
development, specifically looking at lin-149. Through the use of Northern blotting
they unexpectedly identified two small transcripts, lin-4L (61nt) and lin-4S (22nt),
unbeknownst to them that this was the first identification of a pre-miRNA and
mature miRNA respectively. After sequencing it was identified that the lin-4L
transcript had a secondary structure based on complementary sequences within
the transcript, this identified the first defining feature of miRNAs as having a
hairpin structure. Furthermore they identified that the 61nt and 22nt transcript
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had sequence complementarity to the 3’ UTR of lin-14 and recognized that lin-4
could negatively regulate lin-14 translation by RNA-RNA interactions10.
Since then thousands of miRNAs have been identified in many organisms
and studies have begun characterizing functional roles. Studies in Drosophila
have identified important miRNAs like the Bantam miRNA, which stimulates cell
proliferation and prevents apoptosis11. In recent years, miRNAs have been
implicated as important regulators of homeostasis. Of which several studies link
miRNAs that serve as neuroprotectors within aging brains12. miR-181 and miR223 have been identified to regulate glutamate receptors, thereby directing the
postsynaptic receptiveness to glutamate13. Furthermore, miR-485 has been
identified to regulate presynaptically, by tuning expression levels of the synaptic
vesicle protein SV2A, thus regulating the GluR2 receptor expression pattern14. In
human studies, comparative analysis in neuroblastoma, cortical development
and neuronal differentiation of embryonic stem cells, shows that miR-214 and
miR-7 modulate neuronal differentiation and neurite growth 15. Furthermore
perturbed and misregulated miRNA expression patterns have been implied to aid
neurodegenerative disorders16,17.
1.2 miRNA Biogenesis
Encoded within the human genome are thousands of miRNAs, many of
which are deeply conserved18, 19. A common feature among all miRNAs is that
they are derived from hairpin structures20. However, there are numerous classes
of miRNAs; canonical members require RNase III enzyme mediated excision and
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processing, while non-canonical members transit through alternate biogenesis
pathways21.
Production of canonical miRNAs occurs after synthesis of primary miRNA
(pri-miRNAs) transcripts by RNA polymerase II. Pri-miRNAs are identified by the
microprocessor complex component Pasha, which leads to subsequent excision
by Drosha, an RNase III domain-containing enzyme22. After excision the newly
cleaved precursor-miRNA (pre-miRNA) are bound by Exportin-5 and transported
to the cytoplasm in a Ran-GTP dependent manner23. Once within the cytoplasm
another RNase III enzyme Dicer, processes the pre-miRNA to produce an RNA
duplex24. The RNA duplex becomes incorporated into an Ago protein, one RNA
strand, termed the “mature” miRNA, is preferentially loaded into an Ago complex
and guides Ago to complementary mRNA targets 25. The loaded Ago protein is
ready to regulate a target transcript’s expression (Figure 1.1)26.

Figure 1.1 miRNA Biogenesis
Canonical and atypical biogenesis pathways of 3 classes of miRNA
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One variety of non-canonical miRNA is mirtrons27. Mirtrons, which are
found within introns, are independent of Drosha cleavage and are produced by
the spliceosome28. Mirtrons can be further categorized into conventional mirtrons
and tailed mirtrons. Conventional mirtrons are short introns between exons, in
which the splice sites directly meet the base of both hairpin arms29. After splicing
and lariat debranching, the hairpin can continue onto Dicer processing and Ago
loading (Figure 1.1). Tailed mirtrons possess an extended nucleotide tail
attached to one of the hairpin arms, adjacent to either the 5’ or 3’ splice site.
For tailed mirtron synthesis, a precursor-mRNA (pre-mRNA) must be
transcribed by RNA polymerase II30. After transcription of the pre-mRNA, the
spliceosome is recruited to cleave out introns, at the 5’ GU and 3’ AG sites, to
produce a mature exonic mRNA31. Before a hairpin containing intron can
continue through the biogenesis pathway they need debranching by the lariat
debranching enzyme32. Once debranched, mirtrons fold into a hairpin structure
and are ready for tail removal. For 5’ tailed mirtrons, it is not known whether the
tails are cleaved by endonucleases or trimmed by exonucleases. However
studies in Drosophila showed that 3’ tails can be trimmed by an exonuclease, the
RNA exosome33. After tail removal, the hairpin is dicer-processible and the tailed
mirtron continues through the canonical pathway (Figure 1.1).
1.3 Tailed mirtrons: an unexplored area
Over the past two decades, identification of miRNAs has become
increasingly easier with the use of RNA sequencing tools to collect small RNA
reads. Within the human genome, reports have identified 478 mirtron loci, of
4

which 410 belong to the 5’ tailed mirtron class34. This non-canonical population of
miRNA encompasses a quarter of the miRNA loci in humans. miRNAs are being
identified in the thousands for some model organisms and functional roles are
being characterized for abundant canonical miRNA species. However despite the
large population of tailed mirtrons in human, there has been limited to no
research conducted to explore the functional roles of tailed mirtrons.
miR-1017 is a 3’ tailed mirtron which resides within an intron of the
nicotinic acetylcholine receptor alpha-2 subunit, commonly known as nAchR2 or
D2 subunit. Interestingly, the TargetScan algorithm, a miRNA-mRNA targeting
database, predicts miR-1017 can regulate its own host gene, D2. Amongst all
the annotated tailed mirtrons, miR-1017 is by far the most highly expressed and
highly conserved, being present in all 12 of the sequenced Drosophilids35. Due to
the high expression level and deep species conservation of miR-1017, we
hypothesize that miR-1017 has a significant role in Drosophila biology. Therefore
miR-1017 is a prime candidate to explore whether tailed mirtrons possess a
functional role.

5

CHAPTER II – Methods
2.1 Fly strains
w1118, D2-GAL4 (48952), UAS-mCD8::GFP (32184), mir-1017KO/TM3
(58889), Elav-GeneswitchGAL4 (43642), UAS-ArcΑβ42 (33773), UAS-LUC-mir1017/TM3 (41208) were obtained from the Bloomington stock center.
2.2 Construction of luciferase reporters
microRNA binding sites were PCR-amplified, gel purified and ligated into
Psicheck 2 vector (Promega) digested with NotI and XhoI. The D2 ORF
fragment and D5 UTR fragment were ligated downstream of the Renilla
reniformis reporter. D2-F 5’ CTAGGCGATCGCTCGACGAGCTCGCGGCCGCC
TCAAAGATCAAATTCTAACCACCAACG 3’ and D2-R 5’ TTATTGCGGCAGC
GGCCGACTAGTCTCGAGTTGTTGTAGAGCACGATGTCGG 3’. D5-F 5’
CTAGGCGATCGCTCGACGAGCTCGCGGCCGCGGATAAGCGAGGCGTTTT
CATACAAA and D5-R 5’ TTATTGCGGCAGCGGCCGACTAGTCTCGAGGGG
GAATGTGGCGTAATCACTTAG 3’.
Mutant microRNA binding sites were generated by site-directed
mutagenesis using splicing by overlap extension (SOEing) PCR. Two sets of
primers were designed to amplify DNA from regions upstream and downstream
of the mutated segment. These two PCR products were used in a SOEing PCR
with the outside primers to create a product containing the mutated microRNA
binding sites. D2-Mutant-F 5’ GTCACATCTAGGGCTGTGCCATCCGAGCACA
TCTG 3’ and D2-Mutant-R 5’ GCACAGCCCTAGATGTGACGCCGCCATACT
6

CC. D5-Mutant-F 5’ CAATTTGTTCTAGGGCTACTCGTAGTAGGAAACGTAG
GTG 3’ and D5-Mutant-R 5’ GAGTAGCCCTAGAACAAATTGAAGTTTTCCTAA
AAGGTTTGG 3’.
2.3 Luciferase assays
S2 Drosophila cells were plated 1 hour before transfection and
cotransfected in quadruplicate with 50l Grace’s insect medium (Gibco), 1l
TransIT-Insect reagent (Mirus), supplemented with 100ng of Ub-GAL4, 200ng of
UAS-DsRed-miR-1017, and 200ng of Psicheck vector. We performed all assays
72 h after transfection with the dual luciferase assay (Promega) on a Synergy H1
microplate reader (BioTek).
2.4 RT-qPCR
Total RNA was extracted from ~30 fly heads, per condition, with TRI
reagent (MRC). Total RNA was isolated by chloroform phase separation and
DNAse treated. cDNA was synthesized by random primers and Revert AID RT
(Thermo scientific). RT-qPCR was performed using SYBR green (Thermo
scientific). Primers used to assay D2 mRNA levels were F 5’ AGTACGTGG
TCACCACCATGAC 3’ and R 5’ TCTCACAGCTGGACTTGAAGATGG 3’.
Measurements were normalized to ribosomal 18s RNA F 5’ CAAAAAGTTGTGG
ACGAGGCCAAC-3’ and R 5’ GTCCGATCACCGAAATTAAGCAGC 3’.
2.5 Drug feeding
Donepezil (ACROS organics) was dissolved in water and added at a final
concentration of 10μM per gram of standard fly food. Mifepristone (ACROS
organics) was dissolved in 100% ethanol and added at a final concentration of
7

100μM per gram of standard fly food. Food was stored overnight to ensure even
distribution of the drug before use.
2.6 Lifespan assay
Approximately 100 flies of each genotype were reared at 26°C, under a
12h: 12h light: dark cycle. Groups of approximately 20 flies were collected at
eclosion and aged separately. Flies were transferred to fresh food vials every 4
days, and the numbers of dead flies were counted daily.
2.7 Climbing assay
Approximately 40 flies of each genotype were placed in an empty plastic
vial. Flies were tapped to the bottom and the number of flies within the top,
middle, or bottom of the vial were scored after 15 seconds. Experiments were
repeated five times, and a representative result shown.
2.8 Immunocytochemistry
Adult brains of each genotype were dissected in PBS and fixed in 4%
paraformaldehyde for 20 min. Brains were washed five times with PBS
supplemented with 0.1% Triton-X100 (PBT). Brains were blocked with PBT and
5% Goat serum for 1 h at 4°C. Brains were incubated in primary antibody, rabbit
anti-Caspase 3 (1:100, Cell Signalling, #9603S), overnight at 4°C. Brains were
washed three times with PBT. Brains were mounted with DAPI and imaged by
confocal microscopy.
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CHAPTER III - miR-1017 transcriptional regulation of AchRs
3.1 miR-1017 targets Ach receptor subunits
miR-1017 resides within the 4th intron of D2, an acetylcholine (Ach)
receptor subunit gene. Predicted targets of interest generated by TargetScan
were identified as the D2 host transcript and a second nicotinic acetylcholine
receptor alpha-5 subunit, known as D5 or nAchR5. The D2 opening reading
frame contains a miR-1017 8mer site across 8 of the 12 sequenced Drosophilids,
whilst the D5 3’ UTR contains a 8mer site in 9 of the sequenced Drosophilids.
To examine whether miR-1017 had the ability to regulate its own host transcript,
as well as the D5 transcript, we created constructs harbouring either wildtype or
mutated sequences for the miR-1017 binding sites and fused each construct to
the Renilla luciferase coding sequence. The mutant constructs were generated
by SOEing PCR to introduce transversional mutations, of purine to pyrimidine
and vice versa, to the predicted binding sites (Figure 3.1A). A previously
reported yan wildtype and double mutant luciferase construct were used as
known controls33. We cotransfected S2(R+) cells with either wildtype or mutant
Renilla constructs, and ectopically expressed miR-1017 as it is not endogenously
expressed in the S2 culture, using ub-Gal4 and UAS-DsRed-mir-1017. We
confirmed miR-1017 could inhibit the Renilla luciferase sensors, whilst the mutant
constructs exhibit a clear derepression of the Renilla luciferase sensors (Figure
3.1B). Revealing miR-1017 can repress the D2 ORF 5 fold (Student’s T-test; P
< 0.001) and the D5 3’UTR 2 fold (Student’s T-test; P < 0.01).

9

Figure 3.1 Validation of miR-1017 binding sites
miR-1017 acts by regulating acetylcholine receptor transcripts. (A) Predicted target sites for miR-1017 in the D2
opening reading frame and the D

3’-UTR. Red, mutations introduced for mutant Renilla constructs. (B)

Luciferase reporter assay. Control indicates wild type binding sites for miR-1017. Student’s T-test: *** and **
indicates <0.001 and <0.01 respectively.

To examine if miR-1017 regulates similarly in vivo, we acquired mir-1017
flies, which were generated by the Cohen group during their efforts to delete
miRNAs from the fly genome36. As previously stated, miR-1017 has been
identified via northern blotting in the male and female heads33. Therefore RNA
was extracted from Wild type and mir-1017 heads, from Day 2 and Day 25 male
and female heads. We performed RT-qPCR analysis on D2, the host transcript,
to see if miR-1017 exerts similar ability in vivo. Indeed, the level of the D2
mRNA was increased ~5 fold and ~2 fold in RNA isolated from day 2 and day 25
miR-1017 mutant males respectively, compared to wild type males (Figure 3.2,
10

Student’s T-test; P < 0.001, < 0.05). Day 2 miR-1017 mutant females exhibit a
~1.7 fold increase compared to wildtype (Student’s T-test: P < 0.05) whilst day 25
miR-1017 mutant female show no significant difference Figure 3.2).

Figure 3.2 RT-qPCR reveals in vivo regulation of D2 transcript
RT-qPCR revealing in vivo derepression of D2 transcript levels from miR-1017 mutant males and females, aged
day 2 or 25. Values were normalized against wild type flies. Student’s T-test: *** and * indicates <0.001 and <0.05
respectively.

3.2 Identifying the expression pattern of miR-1017
To elucidate the expression pattern of miR-1017 we utilized the
GAL4/UAS system. The GAL4/UAS system has become an important tool to
study gene expression profiles in Drosophila, Zebrafish, cell culture and many
other organisms37, 38. The GAL4/UAS system is widely used in Drosophila, with
thousands of fly stocks. The system involves two factors: the GAL4 gene, which
encodes the yeast transcriptional activator protein GAL4, and an Upstream
Activation Sequence (UAS), an enhancer sequence that GAL4 specifically binds
to activate transcription of a gene of interest or a reporter gene39. In fly lines the
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GAL4 gene is frequently fused to tissue specific endogenous gene promoters,
which allows for transcription of the GAL4 protein within those specified cells.

Figure 3.3 Genetic tools to visualize the D2 expression pattern
Utilization of the GAL4/UAS system used to visualize the miR-1017 host transcript

Within our system we utilized two fly lines, D2-GAL4 and UASmCD8::GFP, to visualize specific tissues within the Drosophila brain which
express D2 and therefore miR-1017. The D2-GAL4 construct drives GAL4
expression under the control of D2 transcriptional enhancer sequences. When
activated by GAL4, the UAS-mCD8::GFP transgene transcribes a membrane
tethered GFP fusion protein, leading to an easily identifiable D2 positive cell. As
both D2-GAL4 and UAS-mCD8::GFP stocks are homozygous, female D2GAL4 and male UAS-mCD8::GFP flies were collected and crossed together
(Figure 3.3). The progeny produced were dissected to inspect GFP expression in
the Drosophila brain.
Using confocal microscopy we observed GFP positive cells in the
suboesophageal (SOG) region, which included both cells within the region and
associated surrounding neuropils (Figure 3.4A&B). The SOG region has a role in
12

processing gustatory signals, in which the region is entangled with sensory
neurons, extended from the proboscis and maxillary palp40. After identifying GFP
labelling within neuropils, we examined whether the expression was isolated to
central nervous system (CNS) neurons, or whether expression included
projections for the peripheral sensory neurons by examining the proboscis and
maxillary palp in 3-day-old pupa. GFP positive cells were identified in both the
proboscis and maxillary palp; therefore suggesting miR-1017 may have a role
within both the central and peripheral nervous system (Figure 3.4C). Lastly GFP
expression was observed within the larval CNS (Figure 3.4D). GFP expression
observed within the CNS, which may implicate that miR-1017 could regulate its
predicted targets during development of the Drosophila head.

Figure 3.4 Visualization of the D2 expression pattern in the CNS
Confocal images showing expression of GFP under Dα2-GAL4 control. A) Expression in the adult CNS in the
SOG. B) Magnification of SOG C) Expression in proboscis and maxillary palp in 3 day pupa. D) Expression in
larval CNS. DAPI in violet
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After examining the D2 GFP expression, we speculated whether there
might be a phenotypic manifestation in those cells in a miR-1017 null
background. To assess whether there is a phenotypic difference we incorporated
the GAL4/UAS system within the mutant background (Figure 3.5). To achieve a
homozygous system, fly stocks containing balancer chromosomes were used.
Balancer chromosomes cannot participate in crossing over events during
meiosis, therefore once our desired transgenes have recombined onto the same
chromosome they were stabilized within the stock. The balancer chromosomes
used in our experiment was MKRS/TM6B, both balancers have dominant marker
phenotypes allowing for easy identification throughout the genetic cross.

Figure 3.5 Incorporating the GAL4/UAS system into mir-1017background
The genetic cross used to establish the GAL4/UAS system within the mir-1017 null background.
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All desired transgenes are located on the 3rd chromosome. Crossing over
during meiosis only occurs within female flies; therefore female progeny from the
first cross were brought forth to the next cross with the balancer chromosome
flies41. The mir-1017 mutant line does not present a phenotypic selective
marker; therefore to insure a successful recombinant we performed PCRs taken
from DNA extracted from the fly legs. The flies which have the recombinant
chromosomes, D2-GAL4,mir-1017 and UAS-mCD8::GFP,mir-1017, were
crossed together to create our transgenic GAL4/UAS system within the mir1017 background.
The wild type females exhibit a low expression of D2 GFP, whilst mutant
female flies show an increased GFP expression (Figure 3.6). The mutant females
had increased GFP suggesting a disruption of a feedback loop, resulting in
higher activation of the D2 enhancer sequences. As GFP expression is a direct
readout of D2 transcriptional we sought to determine if the increased GFP
patterning was attributed to an increase in Ach receptor activity. To test this we
treated wild type females with donepezil, an inhibitor of acetylcholinesterase
(AChE). Inhibition of AChE reduces the degradation of Ach and therefore will
induce an increased Ach receptor activity. Our findings show the donepezil
treated female exerts a high D2 GFP expression pattern (Figure 3.6). These
findings indicate that D2 transcriptional activation may occur by an activity
dependent manner, caused by heightened Ach receptor activity.

15

Figure 3.6 D2 transcription is regulated by AchR activity
D2 GFP expression pattern reveals D2 transcriptional activation is dependent on acetylcholine receptor
activity.
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CHAPTER IV – The neuroprotective role of miR-1017
4.1 miR-1017 neuroprotective role within Drosophila
Previous studies of Alzheimer’s disease (AD) fly models have shown
elevated levels of miR-101742. One of the defining features of AD is increased
firing of background action potentials43. Furthermore increased receptor activity
can cause reactive oxygen species to develop, which subsequently leads to
neuronal cell death44. These Ach receptors have become a focal point for
pharmaceutical drug therapies, including Donepezil an AChE inhibitor, in an
attempt to prevent or dampen AD symptoms45. With our knowledge that miR1017 regulates Ach receptor activity, we began to hypothesize if the elevated
miR-1017 could be a cellular attempt to repress the receptor activity. Therefore to
test whether miR-1017 has a role in preventing a neurotoxic state we performed
neurological assays with mir-1017 and wild type flies.
To assess whether male and female miR-1017 mutant flies undergo
neurodegeneration, we performed a lifespan analysis of male (n=151) and
female (n=150) mutant flies, comparing them to wild type flies (n=135), and
monitored the rate of death daily. mir-1017 males showed a sharply reduced
adult lifespan, with survival declining rapidly between days 20-30. mir-1017
females exhibit a reduced adult lifespan, but not as severe as the male mutants
(Figure 4.1, Cox proportional hazard ratio test; P <0.001 comparing wild type,
miR-1017 male and female).
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Figure 4.1 miR-1017 mutant reduced lifespan
Male and female miR-1017 mutants demonstrate a severely reduced lifespan compared to wild type. Cox
proportional hazard ratio test; P <0.001 comparing wild type, miR-1017 male and female.

Furthermore miR-1017 mutants present an early-onset neurological
deficit when compared to wild type. By day 20, 50-65% of male mutants (n=47)
were impaired in their performance in a climbing assay (Figure 4.2, ANOVA: P
<0.001), and 40-50% female mutants (n=48) were impaired compared to wild
type (n=58) (Figure 4.2, ANOVA; P < 0.05). Male mutants show a greater deficit
compared against female mutants (Figure 4.2, ANOVA; P <0.01). On day 30 both
mutants exhibit severe neurological deficits with males (100%) and females
(87.5%) impaired climbing ability compared to wild type (Figure 4.2, ANOVA, P <
0.001). Furthermore male mutants climbing ability is poorer than the female
mutants (ANOVA; P <0.01). Reduced adult lifespan and neurological deficits are
characteristics of Drosophila models of neurodegeneration46.
18

Figure 4.2 miR-1017 mutants are neurologically impaired
Climbing assay analysis reveals that neurological deficits arise early in miR-1017 mutant males and females,
suggesting an early-onset neurodegeneration.

Moreover we used an antibody against the active form of Caspase 3, to
identify whether mir-1017 mutants were undergoing apoptotic cell death. Both
male and female mir-1017 mutants have a greater population of apoptotic cells
by day 30 compared to the wild type (Figure 4.3). These findings suggest that
miR-1017 mutants are presenting an excitotoxic neurodegeneration.
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Figure 4.3 miR-1017 mutants exhibit an increased amount of apoptosis
Caspase-3 antibody stain on day 30 presents a higher population of apoptotic cells in miR-1017 mutants
compared to wild type.

4.2 Neuroprotection by miR-1017 within a neurodegeneration model
To test whether miR-1017 has a neuroprotective role against an
excitotoxic state we ectopically drove miR-1017 in an AD fly model and
compared it to the control group, to do this we utilized the GAL4/UAS system. To
establish a standardized life expectancy for the AD fly model, two fly lines were
utilized, Elav-Geneswitch:GAL4 and UAS-ArcΑβ42. Elav is a protein exclusively
expressed within neurons, making GAL4 expression localized only to neuronal
cells. The Geneswitch system utilizes the fusion of the ligand-binding domain of
the human progesterone receptor with the transcriptional activation domains of
GAL447. The Geneswitch system was chosen to allow for inducible expression of
the AD transgene after eclosion. Therefore activation of GAL4 required induction
by the steroid mifepristone, which was easily introduced to the adult flies’ diet 48.
20

To ectopically drive miR-1017 in AD fly model a homozygous AD
transgenic stock had to be created. To achieve this we used the
SpHid;LgHid/Sm;TM6B balancer chromosome stock (Figure 4,4).
SpHid;LgHid/Sm;TM6B stock is second (Sm) and third chromosomal (TM6B)
balancers, which contains a copy of the heat shock activated Hid genes, which is
a pro-apoptotic protein49. UAS-ArcΑβ42 (2nd chromosomal) and ElavGeneswitch:GAL4 (3rd chromosomal) were crossed, the desired transgenes were
on separate chromosomes therefore gender of the selected progeny was
unimportant. Progeny was crossed with SpHid;LgHid/Sm;TM6B, the resulting
progeny were heated shocked to select for flies in possession of Sm;TM6B.
Progeny produced that were carriers of both transgenes have an increased depth
of phenotypic red eye therefore those flies were selected for crossing to UASmiR-1017.

Figure 4.4 Introducing ectopically driven miR-1017 into an AD fly model
The genetic cross used to implement ectopically driven miR-1017 in an AD fly model
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To understand whether ectopically driven miR-1017 could dampen or
rescue the AD phenotype, we performed a lifespan analysis. Indeed miR-1017
improved survival of the AD fly model (Figure 4.5, Cox proportional hazard ratio
test; P < 0.001). The AD fly model (n=129) severely declined between days 4555, whilst the miR-1017-AD fly model (n=163) exhibited a declining lifespan
between days 50-60. However 25% of miR-1017-AD flies surpassed the lifespan
of the AD fly model. Both induced AD lines were significantly different to their
uninduced control counterparts (Figure 4.5, Cox proportional hazard ratio test; P
<0.001).

Figure 4.5 Ectopic miR-1017 extends lifespan of AD fly model
Lifespan analysis presents an extension of lifespan of AD flies when miR-1017 is ectopically driven. Mife+/indicates mifepristone induction/uninduced. Cox proportional hazard ratio test; P <0.001 comparing AD against
miR-1017 AD fly model’s.
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Some studies have shown that transgenes can alter lifespan, however our
uninduced lines show no reduced lifespan, of which their comparable lifespan is
not significantly different (Figure 4.5, Cox proportional hazard ratio test; P = 0.71)
Furthermore ectopically driven miR-1017 can rescue climbing ability of the
AD fly model. Day 25 genotypes performed well in the climbing assay. However
the AD fly model (n=43) exhibited a slight reduction in climbing ability with
approximately 20% of flies showing neurological deficits compared to the miR1017-AD fly model (Figure 4.6, ANOVA; P < 0.01). By day 45, the AD fly model
presented severe neurological deficits, with 94% of flies performing poorly in the
climbing assay (Figure 4.6, ANOVA; P < 0.001). In comparison 55% of the miR1017-AD fly model performed poorly in the climbing assay (Figure 4.6, ANOVA;
P < 0.001 compared to the AD fly model). Neither uninduced genotype performed
poorly, and were not significant different (Figure 4.6, ANOVA; P = 0.27). These
findings indicate that miR-1017 can dampen the symptoms exhibited from an
excitotoxic neurodegenerative state. Further supporting the role of miR-1017 as a
cellular response to regulate neurological receptor activity.
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Figure 4.6 Ectopic miR-1017 improves neurological function
Climbing assay analyses demonstrate a deterioration of the AD fly model climbing ability, which ectopic miR1017 improves the climbing ability of the AD fly model.
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CHAPTER V – Discussion
Despite the high population of tailed mirtron loci within the human
genome, no research has been reported that examines the roles of these
miRNAs. The reason for the lack of research conducted may be attributed to the
fact that mirtrons are not highly expressed or well conserved. However this
miRNA species may in fact give rise to species-specific evolution. There are
numerous abundant miRNAs that are broadly expressed across animals because
they are essential for development, however mirtrons seem to be better
conserved amongst close relatives50. When we examine Drosophila miR-1017,
we can clearly see that the 3’ hairpin arm, is deeply conserved. When
considering how miR-1017 became a functionality important miRNA within the
Drosophila species, it’s worth noting that we have identified it regulates AchR
activity. Ach is the neurotransmitter in the CNS for insects, whilst in animal’s
glutamate is the primary CNS neurotransmitter51. Therefore when diverging from
other insects, Drosophila may have incurred a mutation which gave rise to the
birth of miR-1017. Whilst we know that miR-1017 mutants are viable and produce
offspring, they exhibit a reduced lifespan and neurological deficits. Therefore the
birth of miR-1017 may have given rise to a well-maintained neurotransmission
and extended lifespan, which would improve fitness and benefit the evolution of
the Drosophila species. Using Drosophila’s miR-1017 as a candidate, we have
for the first time identified the function and phenotype of one of these miRNA.
Of the 241 predicted binding sites of miR-1017, 86.7% of the predicted
targets are expressed within Drosophila neurons (GSE1060). Of the 209
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predicted target genes, 18 (8.6%) of those are known to be involved in
neurotransmission. Our findings suggest that miR-1017 acts to regulate Ach
receptor transcripts and thereby modulating Ach synaptic transmission.
Luciferase assays and RT-qPCR data revealed derepressed transcript levels in
the miR-1017 mutant constructs and flies, therefore identifying D5 and D2 as
bona fide targets of miR-1017 (Figure 3.1&2). The GFP expression pattern of
D2 transcription indicates males have highly active transcription of the D2
transcript (Data not shown). When considered with the qPCR data which
revealed a near 5 fold depression of the D2 transcript in the male mutants, we
can hypothesize that transcription in males is much higher, and that D2 is being
regulated post-transcriptionally by miR-1017. In comparison, the females
exhibited low GFP patterns, suggesting a much lower activation for D2
transcription. The mutant GFP phenotype presented a slightly higher D2 GFP
expression pattern, consistent with the qPCR data, which may suggest disruption
of a feedback loop. Our hypothesized mechanism is that increased D2
transcript levels and therefore Ach receptors, results in an increase in Ach
neurotransmission, which may in turn promotes transcription of the D2
transcript. This was supported by our donepezil treatment, which phenotypically
showed that increased Ach receptor activity induced by donepezil increased the
D2 GFP pattern, presenting a higher D2 transcriptional activation (Figure 3.6).
This could be further supported by the phenotypic observations made in
the miR-1017 mutants, which exhibit a neurodegeneration. Both male and female
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miR-1017 mutants had a reduced lifespan, performed poorly in the climbing
assays and presented a higher number of apoptotic cells compared to wild type
controls (Figure 4.1&2). Furthermore the male miR-1017 mutants display a
greater neurological deficit than females, potentially due to differentiate
transcriptional expression of D2. Our phenotypic studies support our hypothesis
that miR-1017 serves as a neuroprotective miRNA.
In Drosophila, another neuroprotective miRNA has been identified as miR1000. miR-1000 modulates VGlut mRNA levels, in turn regulating glutamate
synaptic activity. Interestingly they hypothesized that miR-1000 expression was
an activity-dependent mechanism, in which photoreceptor activity regulated miR1000 expression52. With this in mind, we could hypothesize that miR-1017
expression is controlled by an activity dependent mechanism. Our miR-1017
mutant study has revealed an increase in Ach receptor transcripts, which
appears to be caused by increased Ach receptor activity, leads to an excitotoxic
state. However if we consider that a destabilization or an increase in Ach
neurotransmission in a wild type model would lead to transcription of D2 and
thereby miR-1017. The expression of miR-1017 can then act post
transcriptionally to down regulate Ach transcripts, and therefore balance Ach
receptor activity, thereby suggesting an activity dependent mechanism (Figure
5.1). When we treated the GAL4/UAS wild type females with donepezil, an
inhibitor of acetylcholinesterase, we observed a higher GFP expression, which
indicates that D2 transcription is induced by the increased AchR activity caused
by the donepezil treatment.
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Figure 5.1 Proposed mechanism for AchR transcription
Proposed mechanism for AchR transcription (Positive feedback loop) and miR-1017 post-transcriptional
regulation of AchR transcripts (Negative feedback loop).

One of the most common neurodegenerative diseases is Alzheimer’s
disease. The commonly associated pathology is the aggregation of amyloid-β
plaques in the synaptic cleft53. Amyloid-β plaques cause a neurotransmitter
dysregulation, which induces an increased firing of background action
potentials54. The increased ion flux associated with spurious channel activity
results in reactive oxygen species, which in turn induces neuronal apoptosis55.
Pharmaceutical options to treat AD include Donepezil (AChE inhibitor) and
Memantine (glutamate receptor inhibitor), these drugs attempt to improve the
neurological integrity of AD patients, however no pharmaceutical drug has been
proved to be curative. To be understand AD, creation of an AD fly model has
allowed for an in vivo examination of protein-protein interactions and a better
understanding of unknown AD mechanisms56. Interestingly, when we ectopically
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expressed miR-1017 in an AD fly model, we were able to alleviate the
pathogenesis, therefore supporting the repressible activity of miR-1017 in an
excitotoxic state (Figure 4.5&6). Despite presenting a reduced lifespan and poor
climbing ability, the AD fly model did not present a Caspase-3 phenotype. This
may suggest that the ectopically driven Αβ42 plaques may induce a caspase
independent apoptosis57.
To conclude, the importance of this study has elucidated a class of miRNA
that has yet to be studied. Tailed mirtrons, which encompass a quarter of the
miRNA loci in human, have previously been overlooked. Here we demonstrate a
phenotype and role of a 3’ tailed mirtron within Drosophila, therefore identifying
their significance as a miRNA.
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